Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone and Salbutamol in Preschool Wheeze
NCT02319564Phase 4Withdrawn
- Sponsor
- University of Calgary
- Start
- Apr 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing beclomethasone, beclomethasone and salbutamol and Placebo (3 arms). Primary endpoint: Reduce unplanned-symptomatic visits to clinicians at 21 days. Planned start Apr 2016; status: withdrawn.
02
Drugs
beclomethasonesalbutamol
Beyond the preview
Go deeper on NCT02319564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319564.